Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 229

    1.

    Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management.

    Raggi P, Bellasi A, Ratti C.

    Diabetes Care. 2005 Nov;28(11):2787-94. Review.PMID: 16249559 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Coronary artery disease: diagnostic and prognostic models for reducing patient risk.

    Miller DD, Shaw LJ.

    J Cardiovasc Nurs. 2006 Nov-Dec;21(6 Suppl 1):S2-16; quiz S17-9. Review.PMID: 17293746 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of the patient with diabetes mellitus and suspected coronary artery disease.

    Heller GV.

    Am J Med. 2005 Apr;118 Suppl 2:9S-14S. Review.PMID: 15903290 [PubMed - indexed for MEDLINE]Related articles

    5.

    Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus.

    Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, Huisman MV, Jukema JW.

    Diabetologia. 2008 Sep;51(9):1581-93. Epub 2008 Jul 8. Review.PMID: 18607561 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Computed tomography coronary calcium screening and myocardial perfusion imaging.

    Raggi P, Berman DS.

    J Nucl Cardiol. 2005 Jan-Feb;12(1):96-103. Review.PMID: 15682370 [PubMed - indexed for MEDLINE]Related articles

    8.

    Silent myocardial ischemia screening in patients with diabetes mellitus.

    Barthelemy O, Le Feuvre C, Timsit J.

    Arq Bras Endocrinol Metabol. 2007 Mar;51(2):285-93. Review.PMID: 17505636 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus.

    Elhendy A, Huurman A, Schinkel AF, Bax JJ, van Domburg RT, Valkema R, Biagini E, Poldermans D.

    J Nucl Med. 2005 Oct;46(10):1589-95.PMID: 16204707 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.

    Adams GL, Shaw LK, Tuttle RH, Hanson MW, Pagnanelli R, Borges-Neto S.

    Nucl Med Commun. 2007 Jun;28(6):457-63.PMID: 17460536 [PubMed - indexed for MEDLINE]Related articles

    11.

    Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management: Response to Raggi et al.

    Rutter MK, Nesto RW.

    Diabetes Care. 2006 May;29(5):1187; author reply 1188. No abstract available. PMID: 16685801 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Carotid ultrasound assessment of patients with coronary artery disease: a useful index for risk stratification.

    Komorovsky R, Desideri A.

    Vasc Health Risk Manag. 2005;1(2):131-6. Review.PMID: 17315399 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.

    Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB.

    Am J Cardiol. 2004 Jun 3;93(11A):32C-48C. Review.PMID: 15178515 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus.

    Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S, Maddahi J, Cerqueira M.

    Am J Cardiol. 2006 May 15;97(10):1538-44. Epub 2006 Apr 3.PMID: 16679101 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Silent myocardial ischemia in type 2 diabetes. Predictive value of intima-media thickness]

    Boucher B, Cerisier A, Bouchou K, Brulport-Cerisier V, Charmion S, Estour B, Boissier C, Cathébras P.

    Presse Med. 2002 Feb 9;31(5):218-22. French. PMID: 11878140 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prognostic significance of silent coronary artery disease in type 2 diabetes.

    Zellweger MJ.

    Herz. 2006 May;31(3):240-5. Review.PMID: 16770561 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prognostic value of Tc-99m tetrofosmin myocardial perfusion gated SPECT in patients with diabetes mellitus and suspected coronary artery disease.

    Santos MM, Pantoja Mda R, Cwajg E.

    Arq Bras Cardiol. 2008 Jan;90(1):2-10. English, Portuguese. PMID: 18317634 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes.

    Bax JJ, Bonow RO, Tschöpe D, Inzucchi SE, Barrett E; Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes.

    J Am Coll Cardiol. 2006 Aug 15;48(4):754-60. Epub 2006 Jul 24.PMID: 16904545 [PubMed - indexed for MEDLINE]Related articles